Advances in Cardiovascular Toxicity Associated with Targeted Therapy for Breast Cancer

VernacularTitle:乳腺癌靶向治疗相关心血管毒性的研究进展
Author: Yan WANG ^{1
,

2
,

3
,

4
,

5} ; Wenjing MENG ; Zhongsheng TONG
Author Information

1. Department of Breast Medical Oncology, Tianjin Medical University Cancer Institute and Hospital
2. National Clinical Research Center for Cancer
3. Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education
4. Tianjin's Clinical Research Center for Cancer
5. Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
Publication Type:Research Article
Keywords: Breast cancer; Targeted therapy; Cardiovascular toxicity
From: Cancer Research on Prevention and Treatment 2021;48(5):524-529
CountryChina
Language:Chinese
Abstract: Breast cancer is one of the most common malignant tumors in women. Because of the abundance of diagnosis and treatment methods and the wide application of targeted therapy drugs in recent years, the survival time of breast cancer patients is longer than before and the mortality rate shows a downward trend. However, the incidence of cardiovascular toxicity associated with targeted drug therapy in breast cancer patients is also increasing. This article reviews the research progress of cardiovascular toxicity associated with targeted drug therapy in breast cancer.